Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting β2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in England
Comparing adherence to once-daily UMEC/VI, a long-acting muscarinic antagonist/long-acting β2-agonist and twice-daily inhaled corticosteroids in COPD
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 April 2023
|
| In: |
The International journal of chronic obstructive pulmonary disease
Year: 2023, Jahrgang: 18, Pages: 643-659 |
| ISSN: | 1178-2005 |
| DOI: | 10.2147/COPD.S405498 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/COPD.S405498 Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/comparative-effectiveness-of-umeclidiniumvilanterol-versus-inhaled-cor-peer-reviewed-fulltext-article-COPD 
|
| Verfasserangaben: | Alexandrosz Czira, Gema Requena, Victoria Banks, Robert Wood, Theo Tritton, Catherine M. Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J. Rothnie, Felix Herth, Jennifer K. Quint, Afisi S. Ismaila |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1870520416 | ||
| 003 | DE-627 | ||
| 005 | 20240307041630.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231117s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2147/COPD.S405498 |2 doi | |
| 035 | |a (DE-627)1870520416 | ||
| 035 | |a (DE-599)KXP1870520416 | ||
| 035 | |a (OCoLC)1425209534 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Czira, Alexandrosz |e VerfasserIn |0 (DE-588)1310150745 |0 (DE-627)1870521064 |4 aut | |
| 245 | 1 | 0 | |a Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting β2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in England |c Alexandrosz Czira, Gema Requena, Victoria Banks, Robert Wood, Theo Tritton, Catherine M. Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J. Rothnie, Felix Herth, Jennifer K. Quint, Afisi S. Ismaila |
| 246 | 3 | 3 | |a Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting beta 2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in England |
| 264 | 1 | |c 19 April 2023 | |
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Im Text ist "2" tiefgestellt | ||
| 500 | |a Gesehen am 17.11.2023 | ||
| 520 | |a Comparing adherence to once-daily UMEC/VI, a long-acting muscarinic antagonist/long-acting β2-agonist and twice-daily inhaled corticosteroids in COPD | ||
| 700 | 1 | |a Requena, Gema |e VerfasserIn |4 aut | |
| 700 | 1 | |a Banks, Victoria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wood, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tritton, Theo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Castillo, Catherine M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yeap, Jie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wild, Rosie |e VerfasserIn |4 aut | |
| 700 | 1 | |a Compton, Chris |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rothnie, Kieran J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herth, Felix |e VerfasserIn |0 (DE-588)1016095236 |0 (DE-627)705477568 |0 (DE-576)351509925 |4 aut | |
| 700 | 1 | |a Quint, Jennifer K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ismaila, Afisi S. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The International journal of chronic obstructive pulmonary disease |d Albany, Auckland : DOVE Medical Press, 2006 |g 18(2023), Seite 643-659 |h Online-Ressource |w (DE-627)504104357 |w (DE-600)2212419-6 |w (DE-576)312706367 |x 1178-2005 |7 nnas |a Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting β2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in England |
| 773 | 1 | 8 | |g volume:18 |g year:2023 |g pages:643-659 |g extent:17 |a Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting β2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in England |
| 856 | 4 | 0 | |u https://doi.org/10.2147/COPD.S405498 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.dovepress.com/comparative-effectiveness-of-umeclidiniumvilanterol-versus-inhaled-cor-peer-reviewed-fulltext-article-COPD |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20231117 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 1016095236 |a Herth, Felix |m 1016095236:Herth, Felix |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PH1016095236 |e 950000PH1016095236 |e 950900PH1016095236 |e 50000PH1016095236 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 11 | ||
| 999 | |a KXP-PPN1870520416 |e 4410916106 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1870520416","name":{"displayForm":["Alexandrosz Czira, Gema Requena, Victoria Banks, Robert Wood, Theo Tritton, Catherine M. Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J. Rothnie, Felix Herth, Jennifer K. Quint, Afisi S. Ismaila"]},"titleAlt":[{"title":"Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting beta 2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in England"}],"language":["eng"],"title":[{"title_sort":"Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting β2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in England","title":"Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting β2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in England"}],"id":{"doi":["10.2147/COPD.S405498"],"eki":["1870520416"]},"physDesc":[{"extent":"17 S."}],"origin":[{"dateIssuedDisp":"19 April 2023","dateIssuedKey":"2023"}],"person":[{"given":"Alexandrosz","family":"Czira","display":"Czira, Alexandrosz","role":"aut"},{"family":"Requena","given":"Gema","role":"aut","display":"Requena, Gema"},{"given":"Victoria","family":"Banks","display":"Banks, Victoria","role":"aut"},{"family":"Wood","given":"Robert","role":"aut","display":"Wood, Robert"},{"family":"Tritton","given":"Theo","role":"aut","display":"Tritton, Theo"},{"display":"Castillo, Catherine M.","role":"aut","given":"Catherine M.","family":"Castillo"},{"role":"aut","display":"Yeap, Jie","family":"Yeap","given":"Jie"},{"display":"Wild, Rosie","role":"aut","given":"Rosie","family":"Wild"},{"given":"Chris","family":"Compton","display":"Compton, Chris","role":"aut"},{"role":"aut","display":"Rothnie, Kieran J.","family":"Rothnie","given":"Kieran J."},{"role":"aut","display":"Herth, Felix","family":"Herth","given":"Felix"},{"given":"Jennifer K.","family":"Quint","display":"Quint, Jennifer K.","role":"aut"},{"family":"Ismaila","given":"Afisi S.","role":"aut","display":"Ismaila, Afisi S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Im Text ist \"2\" tiefgestellt","Gesehen am 17.11.2023"],"relHost":[{"titleAlt":[{"title":"International journal of COPD"}],"language":["eng"],"part":{"extent":"17","pages":"643-659","volume":"18","year":"2023","text":"18(2023), Seite 643-659"},"pubHistory":["1.2006 -"],"title":[{"title":"The International journal of chronic obstructive pulmonary disease","title_sort":"International journal of chronic obstructive pulmonary disease"}],"recId":"504104357","origin":[{"dateIssuedKey":"2006","publisher":"DOVE Medical Press","publisherPlace":"Albany, Auckland","dateIssuedDisp":"2006-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 02.11.09"],"id":{"eki":["504104357"],"zdb":["2212419-6"],"issn":["1178-2005"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Comparative effectiveness of umeclidinium/vilanterol versus inhaled corticosteroid/long-acting β2-agonist in patients with chronic obstructive pulmonary disease in a primary care setting in EnglandThe International journal of chronic obstructive pulmonary disease"}]} | ||
| SRT | |a CZIRAALEXACOMPARATIV1920 | ||